Day One Biopharmaceuticals Inc (DAWN) — Financial Flexibility Index
Day One Biopharmaceuticals Inc (DAWN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-5.80 Million minus capex $3.82 Million) represents 0% of total liabilities ($62.91 Million). Check Day One Biopharmaceuticals Inc (DAWN) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Day One Biopharmaceuticals Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Day One Biopharmaceuticals Inc across 6 annual periods. See Day One Biopharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Day One Biopharmaceuticals Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Day One Biopharmaceuticals Inc. For the full company profile including market capitalisation, see Day One Biopharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.95x | $-75.94 Million | $-78.11 Million | $80.04 Million | ▲ +80.5% |
| 2023 | -4.87x | $-143.63 Million | $-146.85 Million | $29.51 Million | ▲ +24.6% |
| 2022 | -6.45x | $-109.85 Million | $-109.87 Million | $17.02 Million | ▼ -38.1% |
| 2021 | -4.67x | $-40.54 Million | $-48.54 Million | $8.67 Million | ▲ +23.2% |
| 2020 | -6.09x | $-13.40 Million | $-13.49 Million | $2.20 Million | ▼ -4378.0% |
| 2019 | -0.14x | $-4.42 Million | $-4.51 Million | $32.52 Million | — |